Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Japan Lifeline CoFRA:L8B +1.39%84 PS Ratio is 1.52 as of Jul. 15, 2026, which is 27% below its 10-year median of 2.07. GuruFocus rates FRA:L8B with a GF Score™ of 84/100 and a GF Value™ of €8.11. Among 805 Medical Devices & Instruments companies, Japan Lifeline Co ranks better than 66.58% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Japan Lifeline Co's share price is €7.30.
Japan Lifeline Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €4.79. Hence, Japan Lifeline Co's PS Ratio for today is 1.52.
Good Sign:
Japan Lifeline Co Ltd stock PS Ratio (=1.62) is close to 2-year low of 1.5.
The historical rank and industry rank for Japan Lifeline Co's PS Ratio or its related term are showing as below:
FRA:L8B'
s PS Ratio Range Over the Past 10 Years
Min: 1.35 Med: 2.07 Max: 6.44
Current: 1.63
During the past 13 years, Japan Lifeline Co's highest PS Ratio was 6.44. The lowest was 1.35. And the median was 2.07.
FRA:L8B's PS Ratio is ranked better than 66.58% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 2.88
vs FRA:L8B: 1.63
Japan Lifeline Co Ltd has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue per Share Growth Rate of Japan Lifeline Co was 5.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 8.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 6.10% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 6.10% per year.
During the past 13 years, Japan Lifeline Co's highest 3-Year average Revenue per Share Growth Rate was 23.30% per year. The lowest was -18.70% per year. And the median was 4.30% per year.
Back to Basics: PS Ratio
Japan Lifeline Co (FRA:L8B) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Japan Lifeline Co PS Ratio Related Terms
Japan Lifeline Co PS Ratio Historical Data
* Premium members only.
The historical data trend for Japan Lifeline Co's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Japan Lifeline Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Japan Lifeline Co PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Japan Lifeline Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Japan Lifeline Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Japan Lifeline Co's Share Price of today is €7.30. Japan Lifeline Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €4.79.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Japan Lifeline Co (FRA:L8B) has a PS Ratio of 1.52 as of Jul. 15, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Japan Lifeline Co and its competitors. This is 27% below median its historical median of 2.07. Over the past decade, Japan Lifeline Co's PS Ratio has ranged from 1.35 to 6.44. According to the industry distribution chart, Japan Lifeline Co ranks #269 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 33.4%.
Is Japan Lifeline Co's PS Ratio too high?
Japan Lifeline Co's current PS Ratio of 1.52 is 27% below median its 10-year median of 2.07. Over the past 10 years, this metric has ranged from a low of 1.35 to a high of 6.44. The Medical Devices & Instruments industry median PS Ratio is 2.88. Japan Lifeline Co's value of 1.52 is 47.2% below this industry median. Based on the distribution chart, Japan Lifeline Co ranks #269 out of 805 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Japan Lifeline Co has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Japan Lifeline Co's PS Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Japan Lifeline Co ranks #269 out of 805 companies for PS Ratio. This puts Japan Lifeline Co in the upper half of its industry. The industry median PS Ratio is 2.88. Japan Lifeline Co's value of 1.52 is 47.2% below this benchmark. Historically, Japan Lifeline Co's own PS Ratio has ranged from 1.35 to 6.44 over the past decade. While the company's 10-year median is 2.07 vs. the industry median of 2.88, Japan Lifeline Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.88, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Japan Lifeline Co's current PS Ratio of 1.52 is 47.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Japan Lifeline Co and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Japan Lifeline Co's current PS Ratio is 1.52, which is 27% below median its own 10-year median of 2.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Lifeline Co stock overvalued right now?
Japan Lifeline Co (FRA:L8B) has a current PS Ratio of 1.52. The stock's GF Value™ is €8.11, compared to a current price of €7.30 — trading 10% below its estimated fair value. The current PS Ratio is 1.52, which is 27% below median its 10-year median of 2.07 and 47.2% below the Medical Devices & Instruments industry median of 2.88. Japan Lifeline Co's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Japan Lifeline Co (FRA:L8B), the current PS Ratio is 1.52 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Japan Lifeline Co (FRA:L8B) Overvalued in 2026?
Based on GuruFocus' analysis, Japan Lifeline Co stock appears to be undervalued.
The current stock price of €7.30 is trading 10% below its estimated GF Value™ of €8.11.
Key valuation signals for FRA:L8B:
PS Ratio: 1.52 (27% below median its 10-year median of 2.07)
GF Value™: €8.11 vs. price of €7.30 (10% below fair value)
Industry Position: 47.2% below the Medical Devices & Instruments median (#269 of 805)
No single metric tells the full story. See the FRA:L8B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Japan Lifeline Co Ltd is a medical device company operating in Japan. It is engaged in the trading and manufacturing of medical devices specialized in the cardiovascular field. The company offers medical devices mainly for the treatment of cardiac and vascular diseases. It focuses on providing implantable devices to treat arrhythmias; disposable catheter devices with electrodes for diagnosis and treatment of arrhythmias; prosthetic devices to replace blood vessels and heart valves that lost their functions; and devices for intravascular treatment of cardiac infarction, arterial occlusions of the lower extremities and congenital cardiac diseases.
84GF Score
Get the complete analysis for FRA:L8B
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:L8B has been successfully added to your 
